Johns Hopkins otolaryngologist Kevin Motz discusses hypoglossal nerve stimulator surgery, a secondary treatment option for patients with sleep apnea who are intolerant of CPAP.
mm. I'm dr kevin moz I'm one of the assistant professors in otolaryngology, head and neck surgery here at johns Hopkins. One of my specialties is the management of obstructive sleep apnea. Obstructive sleep apnea is characterized by the repeated collapse of the upper airway during sleep. That leads to sleep fragmentation and oxy hemoglobin saturation at night. The associated risks with untreated obstructive sleep apnea are high for patients, including risks for cerebral vascular diseases where as well as cardiovascular disease. Current treatment strategies for obstructive sleep apnea include continuous positive airway pressure or CPAP an entity most people are familiar with. While CPAP is the first line gold standard treatment for obstructive sleep apnea. It's not tolerated well by all patients as such. Secondary treatment options are critical for these patients to mitigate their risks of cardiovascular and cerebrovascular disease. Over the past 5 to 10 years, alternative therapies in the field of neuro stimulation. Specifically hyper glass cell nerve stimulators have become a primary modality for treating patients who are intolerant to cPAP hippie gospel nerve stimulation aims to treat obstructive sleep apnea by placing an electrode cuff around the hip, a glass cell nerve, the nerve to the tongue and connecting that to an implantable pulse generator in the chest. The patient can activate this device at night and treat or relieve their upper airway obstruction. While this is an effective therapy for many patients, it's not appropriate for all patients with obstructive sleep apnea and a dedicated team of sleep medicine, physicians and otolaryngologist is critical in determining candidacy for these patients. Okay, no. Mhm